Faculty profile

Muhammad Aslam

Back to faculty

Assistant ProfessorMedical OncologyUniversity of Saskatchewan

Muhammad Aslam

Assistant Professor

Medical Oncology

College of Medicine

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
12 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database
Clinical Lymphoma, Myeloma and Leukemia · 2026
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database
Clinical Lymphoma, Myeloma and Leukemia · 2026
Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) Analysis
Clinical Lymphoma, Myeloma and Leukemia · 2025

All 13 publications

Latest funding

The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
CIHR · 2022 · Co-investigator
$1,044,226
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
CIHR · 2021 · Co-investigator
$100,000

All 2 grants and awards

13 publications.

Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

Varghese J, Venner CP, Louzada M, Reece D, White D, Sharma S, Su J, Chu MP, Jimenez-Zepeda VH, McCurdy A

Clinical Lymphoma, Myeloma and Leukemia2026

DOI: 10.1016/j.clml.2025.10.019

Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database

Kaedbey R, Venner CP, Reece D, Hay K, Gul E, Su J, McCurdy A, Chu MP, Jimenez-Zepeda VH, Song K

Clinical Lymphoma, Myeloma and Leukemia2026

DOI: 10.1016/j.clml.2025.10.026

Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) Analysis

McCurdy A, Gul E, Reece D, Chu MP, Jimenez-Zepeda VH, Louzada M, Song K, Mian H, Sebag M, White D

Clinical Lymphoma, Myeloma and Leukemia20252 citations

DOI: 10.1016/j.clml.2025.02.011

Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database

Venner CP, Duggan P, Song K, Reece D, Sharma S, Su J, Jimenez-Zepeda VH, McCurdy A, Louzada M, Mian H

Transplantation and Cellular Therapy20249 citationsOpen Access

DOI: 10.1016/j.jtct.2024.06.030

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, Doucet S, Dudebout J, Fleury I, Fraser G, Larouche JF, Shafey M, Skrabek P, Skamene T, Morin RD, Alcaide M, Ben-Neriah S, Lee D, Winch C, Shepherd LE, Scott DW, Crump M, Chen BE, Hay AE

British journal of haematology20243 citationsOpen Access

DOI: 10.1111/bjh.19764 PMID: 39267295

Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study

Tanguay M, Roy J, Su J, Gul E, Reece D, Venner CP, White D, Chu MP, Jimenez‐Zepada VH, Song K

Cancer Medicine20241 citationsOpen Access

DOI: 10.1002/cam4.70332

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

McCurdy A, Mian H, LeBlanc R, Jimenez-Zepeda VH, Su J, Masih-Khan E, Visram A, Louzada M, Song K, White D

Blood Cancer Journal202320 citationsOpen Access

DOI: 10.1038/s41408-023-00883-x

Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database

Mian H, LeBlanc R, Louzada M, Masih‐Khan E, McCurdy A, Venner CP, Stakiw J, Kardjadj M, Jimenez‐Zepeda VH, Sebag M

Cancer Medicine20235 citationsOpen Access

DOI: 10.1002/cam4.5245

Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis

LeBlanc R, Mian H, Reece D, Su J, Masih‐Khan E, Chu M, Jimenez‐Zepeda V, Sebag M, Song K, Louzada M

European Journal of Haematology20233 citationsOpen Access

DOI: 10.1111/ejh.14082

Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database

LeBlanc R, Mian H, Reece D, Masih‐Khan E, Kardjadj M, Jimenez‐Zepeda VH, McCurdy A, Song K, Sebag M, Louzada M

British Journal of Haematology202214 citations

DOI: 10.1111/bjh.18172

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Muhammad Aslam

Research

Latest papers

Latest funding

Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database

Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) Analysis

Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database

Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis

Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database

The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms

The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms

Frequent collaborators

Martha Louzada

Christopher Venner

Kevin Song

Michael Sebag

Tony Reiman

Arleigh McCurdy

Hira Mian

Donna Reece

Alissa Visram

Jean-François Larouche

Pamela Skrabek

David Lee

Graeme Fraser

Stéphane Doucet

Ryan Morin

Jean Roy

Annette Hay

John Kuruvilla

Kevin Hay

Mona Shafey

David Scott